S J Logistics (India) Regulatory Approval

Management Change

S J Logistics (India) Management Change

S J Logistics' Whole-Time Director Kulshekhar Kumar resigned effective November 6, 2026, citing freight forwarding business realignment. He stays with the group in freight forwarding.

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

S J Logistics (India) Fund Raise of ₹92.58 Cr

SJ Logistics' board approved a preferential issue of equity shares and warrants at Rs.326 each, raising about Rs.92.58 Crore. Shareholder approval is sought at an EGM on 7 December 2026.

Value

₹92.58 Cr

Board Meeting Date

S J Logistics (India) Board Meeting Date

S J Logistics (India) will hold a board meeting on 12 November 2026 to approve unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October 2026 until 14 November 2026.

Credit Rating

S J Logistics (India) Credit Rating

S J Logistics (India) Limited received credit ratings from CARE Ratings for its bank facilities. The company maintains a Stable outlook for these facilities.

Other Announcement

S J Logistics (India) Other Announcement

S J Logistics filed its quarterly Reconciliation of Share Capital Audit under Reg 76 for Q2 FY27. The certificate confirms 1,58,23,130 equity shares match across issued, listed, and demat records.

Annual General Meeting

S J Logistics (India) Annual General Meeting

S J Logistics (India) Limited conducted its 23rd Annual General Meeting on September 23, 2026. Shareholders transacted ordinary and special business items.

Regulatory ApprovalNeogen Chemicals Ltd NEOGENAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.